Tumor mutational analysis of GOG248, a phase II study of temsirolimus or temsirolimus and alternating megestrol acetate and tamoxifen for advanced endometrial cancer (EC): An NRG Oncology/Gynecologic…
Overview of attention for article published in Gynecologic Oncology, April 2016
Altmetric Badge
About this Attention Score
-
Above-average Attention Score compared to outputs of the same age (54th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (58th percentile)
Readers on
- mendeley
- 47 Mendeley